(Q39844384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Role of the protein kinase BRAF in the pathogenesis of endometriosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Claudia Tosti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

9

Charles Chapron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Pietro Santulli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Louis Marcellin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sandrine Chouzenoux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Veronique Boulard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Pierre-Alexandre Just

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Christiane Chereau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Frédéric Batteux

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

4 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

1017-1029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Endometriosis and infertility: pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Sphingosine pathway deregulation in endometriotic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Oxytocin secretion is related to measures of energy homeostasis in young amenorrheic athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Vasculogenesis: a new piece of the endometriosis puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Anti-angiogenic treatment strategies for the therapy of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Oxidative stress and endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Oxidative stress biomarkers in patients with endometriosis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Reactive oxygen species controls endometriosis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Activated AKT pathway promotes establishment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Priorities for endometriosis research: recommendations from an international consensus workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Endometriosis-associated ovarian cancers: pathogenesis and consequences on daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Pigmentary traits, family history of melanoma and the risk of endometriosis: a cohort study of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Targeting the mitogen-activated protein kinase cascade to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Dating the endometrial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Common tasks in microscopic and ultrastructural image analysis using ImageJ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Absence of RIPK3 predicts necroptosis resistance in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Raf-1, a potential therapeutic target, mediates early steps in endometriosis lesion development by endometrial epithelial and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Techniques: species' finest blend--humanized mouse models in inflammatory skin disease research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Raf-1 levels determine the migration rate of primary endometrial stromal cells of patients with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

MAPK signaling pathway and endometriosis: what is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Oncogene addiction: setting the stage for molecularly targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Prostaglandin E2 promotes intestinal tumor growth via DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Correlation of increased concentration of ovine endometrial cyclooxygenase 2 with the increase in PGE2 and PGD2 in the late luteal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Treatment of metastatic malignant melanoma with vemurafenib during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1180367

10.1080/14728222.2016.1180367

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27087167%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference